Fishawack buys Brighton comms agency
pharmafile | July 2, 2014 | News story | Medical Communications | Brighton, Facilitate, comms, fishawack
Medical communications firm Fishawack has acquired the UK, Brighton-based agency Facilitate as part of its ongoing purchasing strategy.
Facilitate will be integrated into the Fishawack Group, and the latter will provide its new acquisition with resources and representation in the US. In doing so, Facilitate will be rebranded as Fishawack-Facilitate.
Facilitate is a full-service med comms agency, and Fishawack says a key attribute to the team is that they have developed a global leadership board service which provides daily content analysis from physicians at key medical congresses.
Established in 2002 by Ann Dieckmann and Alan Bromley, Facilitate has primarily been supporting pharma clients based in the US and Europe. Bromley is to step down from the sector after over 30 years in the business following the acquisition, but Dieckmann is to remain with Facilitate.
Dieckmann says: “I am excited to be part of the Fishawack Group both for myself and for the team. We wanted to become part of a group that has global reach but remained focussed on medical communications.”
Oliver Dennis the chief executive of Fishawack, adds: “Medical communications in the UK is based around an axis that connects Manchester to Oxford to London to Brighton. Being present in those areas puts you within reach of 75% of all experienced medical communications professionals. Brighton is a great place for Fishawack to be.”
Gail Flockhart who is the Group managing director notes that they have been collaborating with Facilitate for the past six months, and have a clear plan for supporting them with additional resource.
She adds: “Facilitate joining the Group brings our global team to over 240 staff, a significant size for an independent organisation in the medical communications sector.”
Brett Wells
Related Content
New support guidelines for NHS whistleblowers
New guidelines to support NHS whistleblowers have been proposed by Sir Robert Francis QC – …
No silver bullet, but a growing arsenal for pharma comms
Digital strategies in the pharma industry have predominately been a red herring, focussing too much …
